ArticleThe Journal of thoracic and cardiovascular surgery2014
The challenge of achieving 1% operative mortality for coronary artery bypass grafting: a multi-institution Society of Thoracic Surgeons Database analysis.
Article in The Journal of thoracic and cardiovascular surgery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- The treatment intensity paradox in stable coronary artery disease: When upstream escalation depletes surgical durability.JTCVS open · 2026Article
- Optimizing CABG in Brazil: Why Superspecialization and Personalized Care Matter Now.Brazilian journal of cardiovascular surgery · 2026Article
- Operating Room Versus Intensive Care Unit Extubation Within 6 Hours After On-Pump Cardiac Surgery: Early Results and Hospital Costs.Seminars in thoracic and cardiovascular surgery · 2024Article
- Cardiac Surgery for Patients Admitted to the Cardiac Intensive Care Unit: Worth the Risk.JACC. Advances · 2023Article
- Presentation and Outcomes of Patients With Preoperative Critical Illness Undergoing Cardiac Surgery.JACC. Advances · 2023Article
- Coronary surgery in women: How can we improve outcomes.JTCVS techniques · 2021Article
- Commentary: When will the robots come marching in?Journal of cardiac surgery · 2021Review
- Mortality risk prediction in high-risk patients undergoing coronary artery bypass grafting: Are traditional risk scores accurate?PloS one · 2021Observational
- Current Impact of Cardiopulmonary Bypass in Coronary Artery Bypass Grafting in São Paulo State.Arquivos brasileiros de cardiologia · 2020Article
- Commentary: Coronary artery bypass grafting in patients with coronavirus disease 2019 (COVID-19): Darkness cannot drive out darkness.The Journal of thoracic and cardiovascular surgery · 2020Article
- A comparison of heparinised and non-heparinised normal saline solutions for maintaining the patency of arterial pressure measurement cannulae after heart surgery.Journal of cardiothoracic surgery · 2019Article
- Comparing Outcomes of Coronary Artery Bypass Grafting Among Large Teaching and Urban Hospitals in China and the United States.Circulation. Cardiovascular quality and outcomes · 2017Observational
- Physiology ofWorld journal of cardiology · 2016Review
- Avoiding Heparinization of Arterial Line and Maintaining Acceptable Arterial Waveform After Cardiac Surgery: A Randomized Clinical Trial.Research in cardiovascular medicine · 2015Article
- Hypothyroidism is a Risk Factor for Atrial Fibrillation after Coronary Artery Bypass Graft.Brazilian journal of cardiovascular surgeryArticle
Corrections and comments
- Commented on byDiscussion.2014
- Commented on by
Authors and funding
7 authors.
Funding
Abstract
objectivesCardiothoracic surgical leadership recently challenged the surgical community to achieve an operative mortality rate of 1.0% for the performance of isolated coronary artery bypass grafting (CABG). The possibility of achieving this goal remains unknown due to the increasing number of high-risk patients being referred for CABG. The purpose of our study was to identify a patient population in which this operative mortality goal is achievable relative to the estimated operative risk.
methodsPatient records from a multi-institution (17 centers) Society of Thoracic Surgeons (STS) database for primary, isolated CABG operations (2001-2012) were analyzed. Multiple logistic regression modeling with spline functions for calculated STS predicted risk of mortality (PROM) was used to rigorously assess the relationship between estimated patient risk and operative mortality, adjusted for operative year and surgeon volume.
resultsA total of 34,416 patients (average patient age, 63.9 ± 10.7 years; 27% [n = 9190] women) incurred an operative mortality rate of 1.87%. Median STS predicted risk of mortality was 1.06% (interquartile range, 0.60%-2.13%) and median surgeon CABG volume was 544 (interquartile range, 303-930) operations over the study period. After risk adjustment for the confounding influence of surgeon volume and operative year, the association between STS PROM and operative mortality was highly significant (P < .0001). More importantly, the adjusted spline function revealed that an STS PROM threshold value of 1.27% correlated with a 1.0% probability of death, accounting for 57.3% (n = 19,720) of the total study population. Further, the STS PROM demonstrated a limited predictive capacity for operative mortality for STS PROM > 25% as observed to expected mortality began to diverge.
conclusionsAchieving the goal of 1.0% operative mortality for primary, isolated CABG is feasible in appropriately selected patients in the modern surgical era. However, this goal may be achieved in only 60% of CABG patients without other improvements in processes of care. Calculated STS PROM can be used to strongly identify patients with estimated mortality risk <1.27% to achieve this goal, but it appears limited in its predictive capacity for those patients with estimated risk >25.0%. These data provide a foundation for further study to determine if 1.0% mortality for CABG is achievable nationwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.